Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
JNK signaling functions to induce defense mechanisms that protect organisms against a variety of different situations. The
sestrin 2
gene, a p53-regulated member of the sestrins family, which lead to AMPK-dependent inhibition of TOR signaling, emerges as a novel player in autophagy induction. However, the relationship between JNK pathway, autophagy induction and
sestrin 2
expression remains elusive. In the present study, we identify JNK as a regulator of autophagy in nasopharyngeal carcinoma cell lines CNE1 and CNE2 exposed to excisanin A or serum deprivation and demonstrate that activation of JNK can cause upregulation of
sestrin 2
expression, which could be blocked by specific siRNAs directed against JNK1/2 or
c-Jun
. Chromatin immunoprecipitation and luciferase reporter analysis revealed that
c-Jun
was transcriptionally involved in the regulation of
sestrin 2
. Furthermore, knockdown of
sestrin 2
by siRNAs similarly inhibited autophagy induction. Moreover, silencing the expression of autophagy related gene ATG5 or
sestrin 2
significantly decreases cell death induced by excisanin A. Our results therefore identify JNK as a novel mediator of
sestrin 2
expression, which plays a key role in autophagy induction following anticancer therapies in cancers.
...
PMID:Upregulation of sestrin 2 expression via JNK pathway activation contributes to autophagy induction in cancer cells. 2298 90
Sestrin-2
(
SESN2
) is involved in the cellular response to different stress conditions. However, the function of
SESN2
in the cardiovascular system remains unknown. In the present study, we tested whether
SESN2
has a beneficial effect on vascular endothelial damage induced by angiotensin II (AngII). Firstly, we found that AngII induces expression of
SESN2
in human umbilical vein endothelial cells (HUVECs) in a time-dependent and dose-dependent manner. We also found that knockdown of
SESN2
using small RNA interference promotes cellular toxicity of AngII, as well as a reduction in cell viability, exacerbation of oxidative stress, and stimulation of apoptosis. In addition, our results show that the
c-Jun
NH (2)-terminal kinase (JNK)/
c-Jun
pathway is activated by AngII. Inhibiting the activity of the JNK pathway abolishes the increase in
SESN2
induced by AngII. Importantly, overexpression of
c-Jun
promotes luciferase activity of the
SESN2
promoter. These findings suggest that the inductive effect of
SESN2
is mediated by the JNK/
c-Jun
pathway. Our results indicate that the induction of
SESN2
acts as a compensatory response to AngII for survival, implying that stimulating expression of
SESN2
might be an effective pharmacological target for the treatment of AngII-associated cardiovascular diseases.
...
PMID:Upregulation of sestrin-2 expression protects against endothelial toxicity of angiotensin II. 2483 22